Pro-Inflammatory Action of MIF in Acute Myocardial Infarction via Activation of Peripheral Blood Mononuclear Cells

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  White, David A ^a,c   Fang, Lu ^a   Chan, William ^b   Morand, Eric F ^c   Kiriazis, Helen ^a   Duffy, Stephen J ^b,c   Taylor, Andrew J ^b,c   Dart, Anthony M ^a,b,c   Du, Xiao Jun ^a,c   Gao, Xiao Ming ^a,c  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; CD68 ANTIGEN; CD74 ANTIGEN; GELATINASE B; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1;

ACUTE HEART INFARCTION; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKOCYTE; MALE; MONOCYTE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STABLE ANGINA PECTORIS; UPREGULATION;

AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES, MONOCLONAL; DISEASE MODELS, ANIMAL; HEART RUPTURE, POST-INFARCTION; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; LEUKOCYTES; LEUKOCYTES, MONONUCLEAR; MACROPHAGE ACTIVATION; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MACROPHAGES; MALE; MICE; MIDDLE AGED; MODELS, BIOLOGICAL; MYOCARDIAL INFARCTION; RISK FACTORS; TIME FACTORS;

EID: 84885078770     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076206     Document Type: Article

References (48)

1. Frangogiannis NG, Smith CW, Entman ML, (2002) The inflammatory response in myocardial infarction. Cardiovasc Res 53: 31-47. doi:10.1016/S0008-6363(01)00434-5. PubMed: 11744011.
2. Frantz S, Bauersachs J, Ertl G, (2009) Post-infarct remodelling: contribution of wound healing and inflammation. Cardiovasc Res 81: 474-481. PubMed: 18977766.
3. Fang L, Gao XM, Moore XL, Kiriazis H, Su Y, et al. (2007) Differences in inflammation, MMP activation and collagen damage account for gender difference in murine cardiac rupture following myocardial infarction. J Mol Cell Cardiol 43: 535-544. doi:10.1016/j.yjmcc.2007.06.011. PubMed: 17689559.
4. Ren G, Dewald O, Frangogiannis NG, (2003) Inflammatory mechanisms in myocardial infarction. Curr Drug Targets Inflamm Allergy 2: 242-256. doi:10.2174/1568010033484098. PubMed: 14561159.
5. Grzybowski M, Welch RD, Parsons L, Ndumele CE, Chen E, et al. (2004) The association between white blood cell count and acute myocardial infarction in-hospital mortality: findings from the National Registry of Myocardial Infarction. Acad Emerg Med 11: 1049-1060. doi:10.1111/j.1553-2712.2004.tb00676.x. PubMed: 15466147.
6. Maekawa Y, Anzai T, Yoshikawa T, Asakura Y, Takahashi T, et al. (2002) Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction:a possible role for left ventricular remodeling. J Am Coll Cardiol 39: 241-246. doi:10.1016/S0735-1097(02)81080-4. PubMed: 11788214.
7. Vinten-Johansen J, (2004) Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res 61: 481-497. doi:10.1016/j.cardiores.2003.10.011. PubMed: 14962479.
8. Weisman HF, Bartow T, Leppo MK, Marsh HC Jr, Carson GR, et al. (1990) Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 249: 146-151. doi:10.1126/science.2371562. PubMed: 2371562.
9. Faxon DP, Gibbons RJ, Chronos NA, Gurbel PA, Sheehan F, (2002) The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study. J Am Coll Cardiol 40: 1199-1204. doi:10.1016/S0735-1097(02)02136-8. PubMed: 12383565.
10. Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT, (2003) Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation 107: 3133-3140. doi:10.1161/01.CIR.0000077913.60364.D2. PubMed: 12796126.
11. Calandra T, Roger T, (2003) Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 3: 791-800. doi:10.1038/nri1200. PubMed: 14502271.
12. Hoi AY, Iskander MN, Morand EF, (2007) Macrophage migration inhibitory factor: a therapeutic target across inflammatory diseases. Inflamm Allergy Drug Targets 6: 183-190. doi:10.2174/187152807781696455. PubMed: 17897055.
13. Makino A, Nakamura T, Hirano M, Kitta Y, Sano K, et al. (2010) High plasma levels of macrophage migration inhibitory factor are associated with adverse long-term outcome in patients with stable coronary artery disease and impaired glucose tolerance or type 2 diabetes mellitus. Atherosclerosis 213: 573-578. doi:10.1016/j.atherosclerosis.2010.09.004. PubMed: 20934703.
14. Kong YZ, Yu X, Tang JJ, Ouyang X, Huang XR, et al. (2005) Macrophage migration inhibitory factor induces MMP-9 expression: implications for destabilization of human atherosclerotic plaques. Atherosclerosis 178: 207-215. doi:10.1016/j.atherosclerosis.2004.08.030. PubMed: 15585220.
15. Burger-Kentischer A, Goebel H, Seiler R, Fraedrich G, Schaefer HE, et al. (2002) Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis. Circulation 105: 1561-1566. doi:10.1161/01.CIR.0000012942.49244.82. PubMed: 11927523.
16. Morand EF, Leech M, Bernhagen J, (2006) MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis. Nat Rev Drug Discov 5: 399-410. doi:10.1038/nrd2029. PubMed: 16628200.
17. Yu CM, Lai KW, Chen YX, Huang XR, Lan HY, (2003) Expression of macrophage migration inhibitory factor in acute ischemic myocardial injury. J Histochem Cytochem 51: 625-631. doi:10.1177/002215540305100508. PubMed: 12704210.
18. Takahashi M, Nishihira J, Katsuki T, Kobayashi E, Ikeda U, et al. (2002) Elevation of plasma levels of macrophage migration inhibitory factor in patients with acute myocardial infarction. Am J Cardiol 89: 248-249. doi:10.1016/S0002-9149(01)02251-2. PubMed: 11792357.
19. Yu CM, Lau CP, Lai KW, Huang XR, Chen WH, et al. (2001) Elevation of plasma level of macrophage migration inhibitory factor in patients with acute myocardial infarction. Am J Cardiol 88: 774-777. doi:10.1016/S0002-9149(01)01850-1. PubMed: 11589847.
20. Fang L, Du XJ, Gao XM, Dart AM, (2010) Activation of peripheral blood mononuclear cells and extracellular matrix and inflammatory gene profile in acute myocardial infarction. Clin Sci (Lond) 119: 175-183. doi:10.1042/CS20100011. PubMed: 20388121.
21. Donnelly SC, Haslett C, Reid PT, Grant IS, Wallace WA, et al. (1997) Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med 3: 320-323. doi:10.1038/nm0397-320. PubMed: 9055860.
22. Benigni F, Atsumi T, Calandra T, Metz C, Echtenacher B, et al. (2000) The proinflammatory mediator macrophage migration inhibitory factor induces glucose catabolism in muscle. J Clin Invest 106: 1291-1300. doi:10.1172/JCI9900. PubMed: 11086030.
23. Cao WG, Morin M, Metz C, Maheux R, Akoum A, (2005) Stimulation of macrophage migration inhibitory factor expression in endometrial stromal cells by interleukin 1beta involving the nuclear transcription factor NFkappaB. Biol Reprod 73: 565-570. doi:10.1095/biolreprod.104.038331. PubMed: 15901641.
24. Gao XM, Dart AM, Dewar E, Jennings G, Du XJ, (2000) Serial echocardiographic assessment of left ventricular dimensions and function after myocardial infarction in mice. Cardiovasc Res 45: 330-338. doi:10.1016/S0008-6363(99)00274-6. PubMed: 10728353.
25. Gao XM, Liu Y, White D, Su Y, Drew BG, et al. (2011) Deletion of macrophage migration inhibitory factor protects the heart from severe ischemia-reperfusion injury: a predominant role of anti-inflammation. J Mol Cell Cardiol 50: 991-999. doi:10.1016/j.yjmcc.2010.12.022. PubMed: 21215754.
26. Liu Y, Gao XM, Fang L, Jennings NL, Su Y, et al. (2011) Novel role of platelets in mediating inflammatory responses and ventricular rupture or remodeling following myocardial infarction. Arterioscler Thromb Vasc Biol 31: 834-841. doi:10.1161/ATVBAHA.110.220467. PubMed: 21252067.
27. Gao XM, Kiriazis H, Moore XL, Feng XH, Sheppard K, et al. (2005) Regression of pressure overload-induced left ventricular hypertrophy in mice. Am J Physiol Heart Circ Physiol 288: H2702-H2707. doi:10.1152/ajpheart.00836.2004. PubMed: 15665058.
28. Gao XM, Xu Q, Kiriazis H, Dart AM, Du XJ, (2005) Mouse model of post-infarct ventricular rupture: time course, strain- and gender-dependency, tensile strength, and histopathology. Cardiovasc Res 65: 469-477. doi:10.1016/j.cardiores.2004.10.014. PubMed: 15639486.
29. Sobierajski J, Hendgen-Cotta UB, Luedike P, Stock P, Rammos C, et al. (2013) Assessment of macrophage migration inhibitory factor in humans: protocol for accurate and reproducible levels. Free Radic Biol Med 63C: 236-242. PubMed: 23707455.
30. Takahashi M, Nishihira J, Shimpo M, Mizue Y, Ueno S, et al. (2001) Macrophage migration inhibitory factor as a redox-sensitive cytokine in cardiac myocytes. Cardiovasc Res 52: 438-445. doi:10.1016/S0008-6363(01)00408-4. PubMed: 11738060.
31. Miller EJ, Li J, Leng L, McDonald C, Atsumi T, et al. (2008) Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart. Nature 451: 578-582. doi:10.1038/nature06504. PubMed: 18235500.
32. Qi D, Hu X, Wu X, Merk M, Leng L, et al. (2009) Cardiac macrophage migration inhibitory factor inhibits JNK pathway activation and injury during ischemia/reperfusion. J Clin Invest 119: 3807-3816. doi:10.1172/JCI39738. PubMed: 19920350.
33. Buratti T, Ricevuti G, Pechlaner C, Joannidis M, Wiedermann FJ, et al. (2001) Plasma levels of procalcitonin and interleukin-6 in acute myocardial infarction. Inflammation 25: 97-100. doi:10.1023/A:1007166521791. PubMed: 11321365.
34. Yin F, Wang YY, Du JH, Li C, Lu ZZ, et al. (2006) Noncanonical cAMP pathway and p38 MAPK mediate beta2-adrenergic receptor-induced IL-6 production in neonatal mouse cardiac fibroblasts. J Mol Cell Cardiol 40: 384-393. doi:10.1016/j.yjmcc.2005.12.005. PubMed: 16466739.
35. Gordon S, Taylor PR, (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5: 953-964. doi:10.1038/nri1733. PubMed: 16322748.
36. Nahrendorf M, Pittet MJ, Swirski FK, (2010) Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation 121: 2437-2445. doi:10.1161/CIRCULATIONAHA.109.916346. PubMed: 20530020.
37. Lindsey M, Wedin K, Brown MD, Keller C, Evans AJ, et al. (2001) Matrix-dependent mechanism of neutrophil-mediated release and activation of matrix metalloproteinase 9 in myocardial ischemia/reperfusion. Circulation 103: 2181-2187. doi:10.1161/01.CIR.103.17.2181. PubMed: 11331260.
38. Ducharme A, Frantz S, Aikawa M, Rabkin E, Lindsey M, et al. (2000) Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest 106: 55-62. doi:10.1172/JCI8768. PubMed: 10880048.
39. Webb CS, Bonnema DD, Ahmed SH, Leonardi AH, McClure CD, et al. (2006) Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction: relation to left ventricular remodeling. Circulation 114: 1020-1027. doi:10.1161/CIRCULATIONAHA.105.600353. PubMed: 16923753.
40. Müller II, Müller KA, Schönleber H, Karathanos A, Schneider M, et al. (2012) Macrophage migration inhibitory factor is enhanced in acute coronary syndromes and is associated with the inflammatory response. PLOS ONE 7: e38376. doi:10.1371/journal.pone.0038376. PubMed: 22693633.
41. Fan H, Hall P, Santos LL, Gregory JL, Fingerle-Rowson G, et al. (2011) Macrophage migration inhibitory factor and CD74 regulate macrophage chemotactic responses via MAPK and Rho GTPase. J Immunol 186: 4915-4924. doi:10.4049/jimmunol.1003713. PubMed: 21411731.
42. Gregory JL, Morand EF, McKeown SJ, Ralph JA, Hall P, et al. (2006) Macrophage migration inhibitory factor induces macrophage recruitment via CC chemokine ligand 2. J Immunol 177: 8072-8079. PubMed: 17114481.
43. Cvetkovic I, Stosic-Grujicic S, (2006) Neutralization of macrophage migration inhibitory factor-novel approach for the treatment of immunoinflammatory disorders. Int Immunopharmacol 6: 1527-1534. doi:10.1016/j.intimp.2006.06.009. PubMed: 16919824.
44. Hayashidani S, Tsutsui H, Ikeuchi M, Shiomi T, Matsusaka H, et al. (2003) Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction. Am J Physiol Heart Circ Physiol 285: H1229-H1235. PubMed: 12775562.
45. Matsusaka H, Ide T, Matsushima S, Ikeuchi M, Kubota T, et al. (2006) Targeted deletion of p53 prevents cardiac rupture after myocardial infarction in mice. Cardiovasc Res 70: 457-465. doi:10.1016/j.cardiores.2006.02.001. PubMed: 16533502.
46. Koga K, Kenessey A, Powell SR, Sison CP, Miller EJ, et al. (2011) Macrophage migration inhibitory factor provides cardioprotection during ischemia/reperfusion by reducing oxidative stress. Antioxid Redox Signal 14: 1191-1202. doi:10.1089/ars.2010.3163. PubMed: 20831446.
47. Bulkley BH, Roberts WC, (1974) Steroid therapy during acute myocardial infarction. A cause of delayed healing and of ventricular aneurysm. Am J Med 56: 244-250. doi:10.1016/0002-9343(74)90603-2. PubMed: 4812079.
48. Roberts R, DeMello V, Sobel BE, (1976) Deleterious effects of methylprednisolone in patients with myocardial infarction. Circulation 53: I204-I206. doi:10.1161/01.CIR.53.1.204. PubMed: 1253361.